Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

In vivo effects of the alpha-synuclein misfolding inhibitor minzasolmin supports clinical development in Parkinson’s disease
D. L. Price, Asma Khan, Rachel Angers, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 16

Showing 16 citing articles:

Parkinson’s Disease: Cells Succumbing to Lifelong Dopamine-Related Oxidative Stress and Other Bioenergetic Challenges
Hirohisa Watanabe, Johannes M. Dijkstra, Toshiharu Nagatsu
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2009-2009
Open Access | Times Cited: 9
Aquaporin-4 and Parkinson’s Disease
К. В. Лапшина, И. В. Екимова
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1672-1672
Open Access | Times Cited: 7
Novel Approaches Targeting in α-Synuclein for Parkinson's Disease: Current Progress and Future Directions for the Disease-Modifying Therapies
David Baggett, Alex Olson, Mayur Parmar
Brain Disorders (2024), pp. 100163-100163
Open Access | Times Cited: 7
Membraneless organelles in health and disease: exploring the molecular basis, physiological roles and pathological implications
Yangxin Li, Brian Liu, Xi‐Yong Yu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 6
“Prion-like” seeding and propagation of oligomeric protein assemblies in neurodegenerative disorders
Silvia Zampar, Sonja E. Di Gregorio, Gustavo Grimmer, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 4
La maladie de Parkinson : de la génétique aux thérapies ciblées
Guillaume Cogan, Alexis Brice
Comptes Rendus Biologies (2025) Vol. 348, Iss. G1, pp. 21-33
Open Access
Current amyloid inhibitors: therapeutic applications and nanomaterial-based innovations
Paula López-García, María M. Tejero-Ojeda, Marisela Morales, et al.
Progress in Neurobiology (2025), pp. 102734-102734
Closed Access
Alpha-Synuclein drives NURR1 and NLRP3 Inflammasome dysregulation in Parkinson's disease: From pathogenesis to potential therapeutic strategies
Ahmed M Abdelaziz
International Immunopharmacology (2025) Vol. 156, pp. 114692-114692
Closed Access
Navigating α‐Synuclein Aggregation Inhibition: Methods, Mechanisms, and Molecular Targets
Maksym Galkin, Anastasiia Priss, Yevhenii Kyriukha, et al.
The Chemical Record (2023) Vol. 24, Iss. 2
Closed Access | Times Cited: 7
Evaluation of the Effect of β-Wrapin AS69 in a Mouse Model Based on Alpha-Synuclein Overexpression
Lennart Höfs, David Geißler-Lösch, Kristof Wunderlich, et al.
(2024)
Open Access | Times Cited: 1
Evaluation and Application of a PET Tracer in Preclinical and Phase 1 Studies to Determine the Brain Biodistribution of Minzasolmin (UCB0599)
Joël Mercier, Massimo Bani, Anny‐Odile Colson, et al.
Molecular Imaging and Biology (2023) Vol. 26, Iss. 2, pp. 310-321
Open Access | Times Cited: 3
Matters arising: In vivo effects of the alpha-synuclein misfolding inhibitor minzasolmin supports clinical development in Parkinson’s disease
Michel A. Steiner
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access
Reply to Matters Arising: In vivo effects of the alpha-synuclein misfolding inhibitor minzasolmin supports clinical development in Parkinson’s disease
D. L. Price, Asma Khan, Rachel Angers, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access
LETC inhibits α-Syn aggregation and ameliorates motor deficiencies in the L62 mouse model of synucleinopathy
Karima Schwab, Silke Frahm, Mandy Magbagbeolu, et al.
European Journal of Pharmacology (2024) Vol. 970, pp. 176505-176505
Open Access
Evaluation of the Effect of β-Wrapin AS69 in a Mouse Model Based on Alpha-Synuclein Overexpression
Lennart Höfs, David Geißler-Lösch, Kristof Wunderlich, et al.
Biomolecules (2024) Vol. 14, Iss. 7, pp. 756-756
Open Access
Imidazo[2,1-b][1,3]thiazine Derivatives as Potential Modulators of Alpha-Synuclein Amyloid Aggregation
Indrė Misiūnaitė, Kamilė Mikalauskaitė, Martyna Paulauskaitė, et al.
ACS Chemical Neuroscience (2024)
Closed Access
Page 1

Scroll to top